Whalesbook
📉 The Financial Deep Dive
Chambal Fertilisers and Chemicals Limited (CFCL) has posted a strong top-line performance for the third quarter and nine months ended December 31, 2025 (Q3/9M FY26). Consolidated operating income surged by 20% YoY to ₹58,983 million in Q3 FY26, and by an even more impressive 27% YoY to ₹1,80,086 million for the nine-month period.
Net profit followed suit, registering a 10% YoY growth to ₹5,864 million in Q3 FY26 and a 17% YoY increase to ₹17,840 million for the nine months. Diluted Earnings Per Share (EPS) rose accordingly by 10% YoY to ₹14.64 and 17% YoY to ₹44.53, respectively.
Margin Compression A Concern:
Despite the revenue and profit growth, a key area for investor scrutiny is the year-on-year decline in EBITDA margins. Consolidated margins for Q3 FY26 stood at 13.92%, down from 15.82% in Q3 FY25. Similarly, for the nine-month period, margins fell from 16.34% in FY25 to 13.46% in FY26. This contraction suggests that either expenses grew faster than revenues or there was a shift in the product mix towards lower-margin offerings.
Income Statement Drivers:
A significant positive factor impacting profitability was the drastic reduction in finance costs, which plunged by 87% YoY for Q3 consolidated and 91% YoY for the nine-month period. This indicates successful debt management or refinancing initiatives. However, 'Other Income' saw a substantial decline YoY, which partially offset the gains from reduced finance costs.
Capital Expenditure & Balance Sheet:
The balance sheet reveals an increase in Total Equity to ₹96,560 million as of H1-FY26 (standalone), up from ₹85,345 million in FY25. The company maintained a Nil Net Debt to Equity ratio as of FY25, underscoring a strong financial footing. A notable increase in Capital Work-in-Progress (CWIP) to ₹11,353 million in H1-FY26 from ₹6,494 million in FY25 points to substantial ongoing capital expenditure, primarily for expansion projects like the Technical Ammonium Nitrate (TAN) facility.
🚩 Risks & Outlook
The Forward View:
While CFCL did not provide specific forward-looking revenue or margin guidance, the company's strategic initiatives offer clear growth drivers. The crucial Technical Ammonium Nitrate (TAN) project is nearing 92.65% completion, with engineering and procurement nearly finalized and construction over 70% complete. This project is expected to be a significant revenue and profit contributor upon commissioning.
Furthermore, the successful launch of 5 new products in the Crop Protection Chemicals (CPC) and Speciality Nutrients (SN) segments during Q3 FY26, coupled with a pipeline of 12 new CPC and 1 SN product for FY27, signals a robust innovation drive. Performance in the Crop Protection Chemicals & Speciality Nutrients segments, along with P&K Fertilisers (due to timely procurement), has been strong.
Key Risks:
The primary risk highlighted is the margin compression observed in Q3 and the nine-month period. Investors will need to closely monitor whether this trend continues or if it was a temporary phenomenon due to input costs or product mix. Additionally, an unscheduled plant stoppage in the Urea segment during Q3 FY26 impacted volumes, posing a short-term operational risk. The absence of explicit management guidance for future periods also leaves a degree of uncertainty for the Street.